Vitamin D
vitaminAlso known as: Cholecalciferol (D3), Ergocalciferol (D2), Calciferol, Calcidiol
About
Vitamin D binds to receptors on cardiomyocytes, vascular smooth muscle, and endothelial cells, regulating calcium handling and the renin-angiotensin-aldosterone system. Observational studies show deficiency (<20 ng/mL) is associated with 50-80% increased cardiovascular risk, though the VITAL trial (25,871 participants) found supplementation did not significantly reduce major cardiovascular events.
How It Works
Binds to vitamin D receptors (VDR) on cardiomyocytes, vascular smooth muscle, and endothelial cells regulating calcium handling and contractile function; modulates the renin-angiotensin-aldosterone system (RAAS) — deficiency upregulates renin contributing to hypertension; suppresses vascular inflammation via NF-kB inhibition; supports endothelial nitric oxide synthase (eNOS) expression.
Evidence For Conditions
| Condition | Grade | Studies | Participants | |
|---|---|---|---|---|
| High Blood Pressure (Hypertension) | C | 20 | 30000 | View → |
| Heart Failure | C | 6 | 3000 | View → |
Side Effects
- Hypercalcemia at very high doses (fatigue, nausea, kidney stones)
- Constipation
- Generally very safe at recommended doses
Drug & Supplement Interactions
- Thiazide diuretics (may increase hypercalcemia risk)
- Statins (theoretical interaction via CYP enzymes)
- Corticosteroids (may reduce vitamin D absorption)
- Weight loss medications (may reduce absorption of fat-soluble vitamins)
Always inform your healthcare provider about all supplements you take.
Related Ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.